Harmony Biosciences to Participate in 24th Annual Needham Virtual Healthcare Conference
Harmony Biosciences (Nasdaq: HRMY) has announced its upcoming participation in the 24th Annual Needham Virtual Healthcare Conference. The company's management team will engage in a fireside chat scheduled for Wednesday, April 9, 2025, at 3:00 p.m. ET.
Interested parties can access the webcast of the discussion through the investor relations section of Harmony's website at https://ir.harmonybiosciences.com/.
Harmony Biosciences (Nasdaq: HRMY) ha annunciato la sua prossima partecipazione alla 24ª Conferenza Virtuale Annuale di Needham sulla Salute. Il team di gestione dell'azienda parteciperà a una conversazione informale programmata per mercoledì 9 aprile 2025, alle 15:00 ET.
Le parti interessate possono accedere alla trasmissione in diretta della discussione attraverso la sezione delle relazioni con gli investitori del sito web di Harmony all'indirizzo https://ir.harmonybiosciences.com/.
Harmony Biosciences (Nasdaq: HRMY) ha anunciado su próxima participación en la 24ª Conferencia Virtual Anual de Salud de Needham. El equipo directivo de la compañía participará en una charla informal programada para miércoles 9 de abril de 2025, a las 3:00 p.m. ET.
Las partes interesadas pueden acceder a la transmisión en vivo de la discusión a través de la sección de relaciones con inversores del sitio web de Harmony en https://ir.harmonybiosciences.com/.
하모니 바이오사이언스 (Nasdaq: HRMY)는 제24회 니덤 연례 가상 헬스케어 컨퍼런스에 참여할 예정이라고 발표했습니다. 회사의 경영진 팀은 2025년 4월 9일 수요일 오후 3시(ET)에 예정된 대담에 참여할 것입니다.
관심 있는 분들은 하모니 웹사이트의 투자자 관계 섹션을 통해 논의의 웹캐스트에 접속할 수 있습니다: https://ir.harmonybiosciences.com/.
Harmony Biosciences (Nasdaq: HRMY) a annoncé sa prochaine participation à la 24e Conférence Virtuelle Annuelle de Needham sur la Santé. L'équipe de direction de l'entreprise participera à une discussion informelle prévue pour mercredi 9 avril 2025, à 15h00 ET.
Les parties intéressées peuvent accéder à la diffusion en direct de la discussion via la section des relations avec les investisseurs du site Web de Harmony à l'adresse suivante : https://ir.harmonybiosciences.com/.
Harmony Biosciences (Nasdaq: HRMY) hat seine bevorstehende Teilnahme an der 24. jährlichen virtuellen Gesundheitskonferenz von Needham angekündigt. Das Management-Team des Unternehmens wird an einem geplanten Gespräch teilnehmen, das für Mittwoch, den 9. April 2025, um 15:00 Uhr ET angesetzt ist.
Interessierte Parteien können über den Bereich für Investorenbeziehungen auf der Website von Harmony auf die Webübertragung der Diskussion zugreifen: https://ir.harmonybiosciences.com/.
- None.
- None.
A webcast of the fireside chat will be available on the investor page of the Harmony Biosciences website at https://ir.harmonybiosciences.com/.
About Harmony Biosciences
Harmony Biosciences is a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases who have unmet medical needs. Driven by novel science, visionary thinking, and a commitment to those who feel overlooked, Harmony Biosciences is nurturing a future full of therapeutic possibilities that may enable patients with rare neurological diseases to truly thrive. Established by Paragon Biosciences, LLC, in 2017 and headquartered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20250326602540/en/
Harmony Biosciences Investor Contact:
Brennan Doyle
484-539-9700
bdoyle@harmonybiosciences.com
Harmony Biosciences Media Contact:
Cate McCanless
202-641-6086
cmccanless@harmonybiosciences.com
Source: Harmony Biosciences Holdings, Inc.
FAQ
When is Harmony Biosciences (HRMY) presenting at the Needham Healthcare Conference 2025?
How can investors watch Harmony Biosciences' (HRMY) Needham Conference presentation?
What type of presentation will HRMY give at the 2025 Needham Healthcare Conference?
Is the 2025 Needham Healthcare Conference where HRMY is presenting virtual or in-person?
